ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.

Julien Giron-Michel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.